参考文献/References:
[1]Wickelgren I. Obesity: how big a problem? Science,1998,280(5368):1364-1367.
[2]刘轶群, 莫朝晖.代谢综合征外科手术治疗的研究进展.北方药学,2012,9(4): 26-28.
[3]Pannain S, Mokhlesi B. Bariatric surgery and its impact on sleep architecture, sleep-disordered breathing, and metabolism. Best Pract Res Clin Endocrinol Metab,2010,24(5):745-761.
[4]Flores L, Vidal J, Canivell S, et al. Hypertension remission 1 year after bariatric surgery: predictive factors. Surg Obes Relat Dis,2014,10(4):661-665.
[5]肖铁刚, 何道同, 邢练军.瘦素、脂联素和抵抗素对代谢综合征患者糖脂代谢和血压调控的影响. 世界华人消化杂志,2014,22(21):3024-3029.
[6]Yatagai T, Nagasaka S, Taniguchi A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism,2003,52(10):1274-1278.
[7]Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem,2002,277(29):25863-25866.
[8]Ong KL, Li M, Tso AW, et al. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol,2010,163(2):251-257.
[9]Di Chiara T, Argano C, Corrao S, et al. Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. J Nutr Metab,2012,2012(10):1-7.
[10]Luo JD，Zhang GS，Chen MS. Leptin and cardiovascular diseases. Timely Top Med Cardiovasc Dis,2005,9(3):34-37.
[11]Quehenberger P, Exner M, Sunder-Plassmann R, et al. Leptin induces endothelin-1 in endothelial cells in vitro. Circ Res,2002,90(6):711-718.
[12]Rosmond R, Chagnon YC, Holm G, et al. Hypertension in obesity and the leptin receptor gene locus. J Clin Endocrinol Metab, 2000,85(9):3126-3131.
[13]Levy BI，Schiffrin EL，Mourad JJ，et al. Impaired tissue perfusion: a pathologycommon to hypertension, obesity, and diabetes mellitus.Circulation, 2008,118(9):968-976．
[14]Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: Mechanisms and clinical implications. Hypertens Res,2011,35(1): 4-16.
[15]Kota SK，Kota SK，Jammula S，et al. Renin-angiotensin system activity in vitaminD deficient，obese individuals with hypertension: an urban Indian study. Indian J Endocrinol Metab, 2011,15(4):395-401.
[16]Sarkhosh K, Birch DW, Shi X, et al. The impact of sleeve gastrectomy on hypertension: a systematic review. Obes Surg,2012,22(5): 832-837.
[17]James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adult: report from the panel members appointed to the English Joint National Committee(JNC 8). JAMA, 2014,311(5):507-520.
[18]朱江帆, 周小刚. 腹腔镜胃袖状切除术临床应用价值.中国实用外科杂志,2014,34(11):1032-1035.
[19]Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg，2003,23(7):751-756.
[20]Hinojosa MW, Varela JE, Smith BR, et al. Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg,2009,13(4): 793-797.
[21]Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA,2004,292(14):1724-1737.
[22]Huerta S, Kohan D, Siddiqui A, et al. Livingston EH. Assessment of comorbid conditions in veteran patients after Roux-en-Y gastric bypass. Am J Surg,2007,194(1):48-52.
[23]Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med,2005,142(7):547-559.
[24]沈迪建, 王跃东. 手术治疗2型糖尿病研究进展. 中华外科杂志,2013,51(6):562-564.
[25]Dixon JB, Zimmet P, Alberi KG. et al. Bariatric surgery: an IDF statement for obese type 2 diabetes. Diabet Med,2011,28(21):628-642.
[26]da Silva AA, do Carmo J, Dubinion J, et al. The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep,2009,11(3):206-211.
[27]Dorresteijn JA, Visseren FL, Spiering W. Mechanisms linking obesity to hypertension. Obes Rev,2012,13(1):17-26.
[28]Weyer C, Pratley RE, Snitker S, et al. Ethnic differences in insulinemia and sympa-thetic tone as links between obesity and blood pressure. Hypertension,2000,36(4):531-537.
[29]Jacques H, Guy-Bernard C, Michel B, et al. Long-term Outcomes of Laparoscopic Adjustable Gastric Banding. Arch Surg,2011,146(7):802-807.
[30]De Angelis K, Senador DD, Mostarda C, et al. Sympathetic overactivity precedes metabolic dysfunction in a fructose model of glucose intolerance. Am J Physiol,2012,302(8):R950-R957.
[31]Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol,2013,305(6):R566-R581.
[32]Rahmouni K，Fath M A，Seo S, et al. Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J Clin Invest,2008,118(4):1458-1467.
[33]Kalil GZ, Haynes WG. Sympathetic nervous system in obesity-related hypertension: Mechanisms and clinical implications. Hypertens Res,2011,35(1):4-16.
[34]Fruhbeck G. Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes,1999,48(4):903-908.
[35]Bravo PE, Morse S, Borne DM, et al. Leptin and hypertension in obesity. Vasc Health Risk Manag,2006,2(2):163-169.
[36]Razny U, Kiec-Wilk B, Polus A, et al. The adipose tissue gene expression in mice with different nitric oxide availability. J Physiol Pharmacol,2010,61(5):607-618.
[37]Vila G, Riedl M, Maier C, et al. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity,2009,17(6):1184-1188.
[38]罗益滨, 朱天怡, 陈震,等.肥胖性高血压机制研究进展.第二军医大学学报,2010,31(4):442-444.